Literature DB >> 28078490

Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells.

Hidenao Toyoda1, Yuko Nagai2, Aya Kojima2, Akiko Kinoshita-Toyoda2.   

Abstract

Podocalyxin (PC) was first identified as a heavily sialylated transmembrane protein of glomerular podocytes. Recent studies suggest that PC is a remarkable glycoconjugate that acts as a universal glyco-carrier. The glycoforms of PC are responsible for multiple functions in normal tissue, human cancer cells, human embryonic stem cells (hESCs), and human induced pluripotent stem cells (hiPSCs). PC is employed as a major pluripotent marker of hESCs and hiPSCs. Among the general antibodies for human PC, TRA-1-60 and TRA-1-81 recognize the keratan sulfate (KS)-related structures. Therefore, It is worthwhile to summarize the outstanding chemical characteristic of PC, including the KS-related structures. Here, we review the glycoforms of PC and discuss the potential of PC as a novel KS proteoglycan in undifferentiated hESCs and hiPSCs.

Entities:  

Keywords:  Embryonic stem cells; Glycosaminoglycans; Induced pluripotent stem cells; Keratan sulfate; Podocalyxin

Mesh:

Substances:

Year:  2017        PMID: 28078490     DOI: 10.1007/s10719-016-9757-0

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  68 in total

1.  Microanalysis of glycosaminoglycan-derived oligosaccharides labeled with a fluorophore 2-aminobenzamide by high-performance liquid chromatography: application to disaccharide composition analysis and exosequencing of oligosaccharides.

Authors:  A Kinoshita; K Sugahara
Journal:  Anal Biochem       Date:  1999-05-01       Impact factor: 3.365

Review 2.  Stem cell states, fates, and the rules of attraction.

Authors:  Tariq Enver; Martin Pera; Carsten Peterson; Peter W Andrews
Journal:  Cell Stem Cell       Date:  2009-05-08       Impact factor: 24.633

3.  High-molecular-weight glycoproteins of human teratocarcinoma defined by monoclonal antibodies to carbohydrate determinants.

Authors:  W J Rettig; C Cordon-Cardo; J S Ng; H F Oettgen; L J Old; K O Lloyd
Journal:  Cancer Res       Date:  1985-02       Impact factor: 12.701

4.  Microdetermination of hyaluronan in human plasma by high-performance liquid chromatography with a graphitized carbon column and postcolumn fluorometric detection.

Authors:  Hidenao Toyoda; Fumie Muraki; Toshio Imanari; Akiko Kinoshita-Toyoda
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-03-10       Impact factor: 3.205

5.  Structure and biosynthesis of proteoglycans with keratan sulfate.

Authors:  V C Hascall
Journal:  Prog Clin Biol Res       Date:  1982

6.  Analytical method for keratan sulfates by high-performance liquid chromatography/turbo-ionspray tandem mass spectrometry.

Authors:  T Oguma; H Toyoda; T Toida; T Imanari
Journal:  Anal Biochem       Date:  2001-03-01       Impact factor: 3.365

7.  The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice.

Authors:  Ryang Hwa Lee; Min Jeong Seo; Andrey A Pulin; Carl A Gregory; Joni Ylostalo; Darwin J Prockop
Journal:  Blood       Date:  2008-09-25       Impact factor: 22.113

8.  Profiling of the eye aqueous humor in exfoliation syndrome by high-performance liquid chromatographic analysis of hyaluronan and galactosaminoglycans.

Authors:  F Lamari; J Katsimpris; S Gartaganis; N K Karamanos
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1998-05-29

9.  Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells.

Authors:  P W Andrews; G Banting; I Damjanov; D Arnaud; P Avner
Journal:  Hybridoma       Date:  1984

10.  Thrombomucin, a novel cell surface protein that defines thrombocytes and multipotent hematopoietic progenitors.

Authors:  K M McNagny; I Pettersson; F Rossi; I Flamme; A Shevchenko; M Mann; T Graf
Journal:  J Cell Biol       Date:  1997-09-22       Impact factor: 10.539

View more
  4 in total

1.  Overexpression of the Pluripotent Stem Cell Marker Podocalyxin in Prostate Cancer.

Authors:  Elisabeth I Heath; Lance K Heilbrun; Daryn Smith; William M Schopperle; Yawen Ju; Susan Bolton; Quratulain Ahmed; Wael A Sakr
Journal:  Anticancer Res       Date:  2018-11       Impact factor: 2.480

2.  Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma.

Authors:  Shunsuke Itai; Tomokazu Ohishi; Mika K Kaneko; Shinji Yamada; Shinji Abe; Takuro Nakamura; Miyuki Yanaka; Yao-Wen Chang; Shun-Ichi Ohba; Yasuhiko Nishioka; Manabu Kawada; Hiroyuki Harada; Yukinari Kato
Journal:  Oncotarget       Date:  2018-04-27

3.  Determination of critical epitope of PcMab-47 against human podocalyxin.

Authors:  Shunsuke Itai; Shinji Yamada; Mika K Kaneko; Yukinari Kato
Journal:  Biochem Biophys Rep       Date:  2018-04-24

Review 4.  Concise Review: Stem/Progenitor Cell Proteoglycans Decorated with 7-D-4, 4-C-3, and 3-B-3(-) Chondroitin Sulfate Motifs Are Morphogenetic Markers of Tissue Development.

Authors:  Anthony J Hayes; Susan M Smith; Bruce Caterson; James Melrose
Journal:  Stem Cells       Date:  2018-07-31       Impact factor: 6.277

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.